Navigation Links
NxStage Names Joseph Turk President, North America

LAWRENCE, Mass., Dec. 20, 2010 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Joseph E. Turk, Jr., has been promoted to the position of President of its North American operations.  Reporting to Jeffrey Burbank, Chief Executive Officer of NxStage, Mr. Turk will continue to manage the Company's North American commercial teams across the Company's three markets (Home, Critical Care, and In-Center) and will be responsible for driving NxStage's worldwide product portfolio.

"Joe has been a driving force behind the Company's ability to successfully execute against its strategic initiatives and achieve its goals," said Jeffrey Burbank, Chief Executive Officer of NxStage.  "As the scale of our business increases, Joe's exceptional track record as a multi-faceted operating executive will be a great asset to our growth initiatives across all three of our markets."

Mr. Turk, age 43, joined NxStage Medical in 2000 as Vice President of Marketing. He served as Vice President of Sales and Marketing from 2002 to 2006, and most recently served as Senior Vice President of Commercial Operations since 2006.

"NxStage is a great company with a tremendous future and growth opportunities across all its markets, and I feel privileged to have worked with such a talented team in achieving our milestones to date," said Mr. Turk. "I am proud of this recognition and I look forward to continuing to deliver value to our patients, customers, partners, and all of our stakeholders."

Before joining NxStage, Mr. Turk served as Director of New Business Development at Boston Scientific. Prior to this, he was one of the leaders of McKinsey & Company's Midwest Health Care and Biotechnology Practice as a Senior Engagement Manager in the firm's Chicago Office.  

Mr. Turk received his AB in Economics from Wabash College and an MBA in Marketing, Finance and Operations from Northwestern University's J.L. Kellogg School.

About NxStage Medical, Inc.

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of End Stage Renal Disease (ESRD) and acute kidney failure. For more information on NxStage and its products, please visit NxStage's website at

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors that are discussed in NxStage's Quarterly Report on Form 10-Q for the period ended September 30, 2010 filed with the SEC. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

NxStage Medical:

Kristen K. Sheppard, Esq.

VP, Investor Relations

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First NxStage® Home Hemodialysis Patients Celebrate Seven-Year Anniversary
2. NxStage Announces Fourth Quarter 2010 Investor Conference Schedule
3. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
4. NxStage to Report Third Quarter Fiscal 2010 Financial Results
5. NxStage(R) Secures $15 Million Revolving Line of Credit
6. NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
7. Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
8. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
9. NxStage(R) Reports Significant Interim FREEDOM Study Results
10. NxStage(R) to Report Third Quarter 2009 Financial Results
11. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer ... through a fitness app. The fitness app plans to fix the two major problems leading ... a one size fits all type program , They don’t eliminate all the ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):